Senate Bill 45

149th General Assembly (2017 - 2018)

Bill Progress

Signed 7/17/17
The General Assembly has ended, the current status is the final status.

Bill Details

3/30/17
Rep. Bentz
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
This Bill adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of the Uniform Controlled Substances Act. U-47700, also known as “Pink,” is a synthetic opioid recently encountered by law enforcement and public health officials and is being abused for its opioid properties. It is available over the Internet and is marketed as a “research chemical.” The safety risks to users are significant and the public health risks include large numbers of drug treatment admissions, emergency room visits and fatal overdoses. On November 14, 2016, the Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I for a two-year period, finding that this synthetic opioid has a high potential for abuse, no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. By Emergency Order dated December 15, 2016, the Secretary of State temporarily placed U-47700 in Schedule I. This Order is effective for 120 days. The permanent addition of U-47700 to Schedule I is required in the interest of public protection.
81:77
Not Required
7/17/17

Bill Text

View HTML View PDF
You may need to disable your browser's pop-up blocker to view linked documents.

Amendments

AmendmentStatusIntroduction DatePrimary SponsorView Details

Committee Reports

DateCommittee# MembersFavorableOn Its MeritsUnfavorable 

Roll Calls

ChamberResultDateVote TypeYesNoNot VotingAbsentPDF

Actions History

DateAction

Legislation Detail Feeds